LEANNE GLIDEWELL: Open Payments
NPI 1073852877 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$380 in 15 payments from 7 companies in 2025. Trend: 2023 $419 · 2024 $489 · 2025 $380
Food & beverage: $380
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $155 |
| Novo Nordisk Inc | 1 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $50 |
| ABBVIE INC. | 2 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| Dexcom, Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: ZEPBOUND, Wegovy, MOUNJARO, CAPLYTA, VRAYLAR, SPRAVATO, Dexcom G6 Transmitter, JARDIANCE.
Industry payments across AR — which companies pay providers there.
